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Deficiencies in natural Killer cell 
numbers, expansion, and Function 
at the Pre-neoplastic stage  
of Pancreatic cancer by Kras  
Mutation in the Pancreas  
of Obese Mice
Kawaljit Kaur1, Hui-Hua Chang2, Paytsar Topchyan1, Jessica Morgan Cook1,  
Andre Barkhordarian1, Guido Eibl2 and Anahid Jewett1,3,4*
1 Division of Oral Biology and Oral Medicine, School of Dentistry and Medicine, University of California, Los Angeles,  
Los Angeles, CA, United States, 2  Department of Surgery, David Geffen School of Medicine, University of California, Los 
Angeles, Los Angeles, CA, United States, 3 Department of Tumor Immunology, School of Dentistry and Medicine, University of 
California, Los Angeles, Los Angeles, CA, United States, 4 UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, 
United States
The combined/synergistic effect of genetic mutation of KRAS in the pancreas 
and obesity, a life-style factor on suppression of natural killer (NK) cells at the pre- 
neoplastic stage of pancreatic cancer has not been investigated and is the subject of 
this report. Obese mice with KRAS (KC) mutation in the pancreas fed with high-fat cal-
orie diet (HFCD) exhibit severe deficiencies in the NK cell expansion and function at the 
pre-neoplastic stage of pancreatic cancer. Decreased NK cell-mediated cytotoxicity is 
observed in the peripheral blood, spleen, pancreas, and peri-pancreatic adipose tissue 
in obese KC mice, whereas in bone marrow an increased NK cell-mediated cytotoxicity 
is observed when compared to lean WT mice fed with control diet (CD). Obese KC mice 
on HFCD demonstrated the least ability to expand NK cells or induce NK cell-mediated 
cytotoxicity when compared to the other groups of mice. Indeed, the following profile 
WT/CD > WT/HFCD > KC/CD > KC/HFCD was seen for the ability to expand NK cells 
or mediate cytotoxicity among four groups of mice in spleen, peripheral blood, pancreas, 
and peri-pancreatic adipose tissue. Sorted NK cells from the splenocytes of four groups 
of mice also exhibited the same profiles for the cytotoxicity as the unsorted splenocytes, 
and a decreased IFN-γ secretion could be seen in cultures of NK cells from KC mice fed 
with either CD or HFCD. Cultures of NK cells with autologous monocytes from obese 
KC mice fed with HFCD exhibited decreased cytotoxicity and IFN-γ secretion, whereas 
cultures of allogeneic NK cells from WT mice fed with CD with osteoclasts of obese mice 
fed with HFCD demonstrated decreased cytotoxicity but augmented IFN-γ secretion. 
Increased IL-6 along with decreased IFN-γ and cell-mediated cytotoxicity by the NK 
cells, within NK-adipose tissue of KC/HFCD mice, may provide safe microenvironment 
for the expansion of pancreatic tumors.
Keywords: natural killer cells, Kras, iFn-γ, hFcD, control diet, pre-neoplastic lesions
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highlighTs
•	 KRAS	 mutation	 of	 pancreas	 and/or	 feeding	 with	 HFCD	 is	
associated	with	 the	 significant	 loss	 of	NK  cell	 numbers	 and	
function
•	 NK cell	defect	 in	mice	with	KRAS	mutation	and/or	fed	with	
HFCD	occurs	at	the	pre-malignant	stage	of	pancreatic	cancer
•	 NK  cell	 defects	 are	 seen	 during	 activation	 of	 NK  cells	 by	
autologous	monocytes	 in	mice	with	KRAS	mutation	 and/or	
fed	with	HFCD
•	 Osteoclasts	 from	mice	with	KRAS	mutation	and/or	 fed	with	
HFCD	have	decreased	RAE1-delta	activating	as	well	as	inhibi-
tory	MHC-class	I	surface	receptors,	and	are	less	able	to	expand	
NK cells
•	 Decreased	 killing	 but	 augmented	 IFN-γ	 is	 observed	 when	
allogeneic	 NK  cells	 obtained	 from	 WT	 mice	 interact	 with	
osteoclasts	from	KC	mice	on	HFCD.
sUMMarY
We	have	previously	 shown	 that	NK  cells	 select	 and	differenti-
ate	 cancer	 stem	cells	 (CSCs)/undifferentiated	 tumors	by	direct	
killing	of	CSCs	and	secretion	of	 IFN-γ	which	 lead	 to	differen-
tiation	of	CSCs,	respectively.	These	are	two	important	functions	
of	 NK  cells	 which	 prevent	 establishment	 and	 progression	 of	
cancer.	Here,	we	show	defects	 in	expansion,	killing,	and	secre-
tion	of	IFN-γ	by	NK cells	 in	mice	which	have	KRAS	mutation	
in	 pancreas	 and/or	 are	 fed	 with	 HFCD	 at	 the	 pre-cancerous	
stage.	NK cell-mediated	killing	is	always	defective	in	these	mice;	
however,	depending	on	the	extent	of	defect	in	either	NK cells	or	
in	the	cells	that	interact	with	NK cells	or	both,	the	secretion	of	
IFN-γ	could	be	variable	effecting	differentiation	of	cancer	stem	
cells.	Increased	IL-6	secretion	in	the	presence	of	decreased	IFN-γ	
secretion	induced	by	surrounding	or	infiltrating	adipose	tissue	
within	 tumor	 microenvironment	 may	 constitute	 a	 significant	
driving	force	in	the	expansion	of	pancreatic	tumors.
inTrODUcTiOn
Pancreatic	ductal	adenocarcinoma	(PDAC)	constitutes	over	90%	
of	 pancreatic	 cancers,	 and	 is	 the	 fourth	 most	 severe	 cause	 of	
cancer-related	deaths	worldwide,	with	a	5-year	survival	rate	of	less	
than	5%	(1–5).	The	genes	mutated	in	pancreatic	cancer	include	
KRAS2,	p16/CDKN2A,	TP53,	and	SMAD4/DPC4	in	combina-
tion	with	 genomic	 and	 transcriptomic	 alterations	 facilitate	 cell	
cycle	deregulation,	cell	survival,	invasion,	and	metastases	(2,	6,	7).	
In	most	cases,	PDAC	is	initiated	by	the	oncogenic	mutant	KRAS	
which	has	been	shown	to	drive	pancreatic	neoplasia	(8).	KRAS	
mutations	are	associated	with	 reduced	patient	 survival	 in	both	
malignant	exocrine	and	PDAC	(9,	10).
Obesity	 can	 lead	 to	 intra-pancreatic	 fatty	 infiltration	 and	 is	
associated	 with	 an	 increased	 risk	 of	 pancreatic	 cancer	 and	 its	
precursor	lesions	(11–13).	Because	of	high	prevalence	of	obesity	
in	the	United	States,	greater	attention	must	be	given	to	its	preven-
tion	 and	management	 (14).	 Impaired	 immune	 function	 in	 the	
presence	of	excess	adipose	tissue	has	been	demonstrated	both	in	
humans	and	genetically	obese	rodents	(15–17).	It	was	previously	
shown	 that	 high-fat	 diet	 significantly	 elevated	 the	 pancreatic	
neoplasm	incidence	(18,	19).	However,	it’s	effect	on	natural	killer	
(NK)	 cell	 expansion	 and	 function	 which	 constitutes	 first	 line	
of	defense	 against	 establishment	 and	progression	of	pancreatic	
tumors	has	not	been	clearly	established.
Natural	Killer	cells	are	large	granular	lymphocytes	function-
ing	 at	 the	 interface	of	 innate	 and	adaptive	 immunity	 (20,	 21).	
NK cells	develop	in	the	bone	marrow.	The	frequencies	of	NK cells	
within	the	lymphocyte	populations	are	heterogeneous	in	differ-
ent	tissues,	constituting	about	3–10%	of	circulating	lymphocytes	
and	those	within	the	secondary	lymphoid	organs	(22,	23).	Early	
mature	murine	NK cells	are	identified	by	their	surface	expression	
of	CD49b	(DX5)	or	NK1.1	(24).	The	majority	of	DX5	express-
ing	mature	NK  cells	 are	 found	 in	 various	 lymphoid	 and	non-
lymphoid	peripheral	tissues	(25,	26).	The	activation	of	NK cells	is	
controlled	by	the	balance	between	the	activating	and	inhibitory	
receptors	(27–32).	The	activating	receptors	expressed	by	NK cells	
commonly	recognize	host	or	pathogen	glycoproteins,	and	inhibi-
tory	receptors	commonly	recognize	MHC-class	I	molecules	(29,	
33–35).	NK cells	recognize	CSCs	and	virus-infected	cells	without	
prior	sensitization	both	in	humans	and	mice	(36–39),	targeting	
them	by	releasing	pre-formed	granules	of	proteins	perforin	and	
granzyme	B,	which	can	induce	necrotic	as	well	as	apoptotic	cell	
death	in	target	cells	(40–42).	NK cells	or	their	precursors	move	
from	the	spleen	toward	pancreas,	where	they	display	an	activated	
phenotype,	exhibiting	higher	IFN-γ	secretion	and	upregulation	
of	 CD69	 and	 CD25	 activation	 receptors	 (43).	 A	 reason	 for	
pancreatic	cancer’s	resilience	toward	intensive	treatments	is	 its	
ability	to	inhibit	the	immune	system	in	such	a	way	that	during	
disease	progression	the	immune	system	becomes	permissive	to	
tumor	establishment,	instead	of	eliminating	it	(44).	It	is	suggested	
that	fatty	infiltration	of	pancreas	is	a	risk	factor	for	the	induction	
and	progression	of	PDAC	(45,	46).	In	addition	to	secreting	IL-6,	
peri-pancreatic	and	pancreatic	adipose	tissues	contribute	to	the	
production	of	a	number	of	inflammatory	cytokines	and	growth	
factors	which	may	drive	the	growth	and	expansion	of	pancreatic	
tumors	 (47–49).	 However,	 the	 underlying	mechanisms	 of	 the	
contribution	 of	 fatty	 infiltrate	 in	 tumor	 induction	 have	 not	
been	elucidated.	High	numbers	of	NK cells	contribute	to	better	
prognosis	in	pancreatic	adenocarcinoma	patients	(50).
We	have	 recently	 shown	 that	 a	decrease	 in	 cytotoxicity	 and	
lower	 IFN-γ	 secretion	 by	 osteoclast-expanded	 NK  cells	 both	
from	 pancreatic	 cancer	 patients	 and	 tumor-bearing	 human-
ized	 BLT	 (hu-BLT)	 mice	 correlates	 with	 faster	 expansion	 of	
residual	contaminating	T cells	within	purified	NK cells,	whereas	
osteoclast-expanded	NK cells	from	healthy	human	donors’	and	
hu-BLT	mice	with	no	tumors	continue	expanding	super	charged	
NK cells,	while	limiting	T cell	expansion	for	up	to	30	to	60 days	
(51).	We	have	also	shown	that	expansion	of	T cells	correlates	with	
the	decline	in	NK cell-mediated	cytotoxicity	and	secretion	of	key	
cytokines,	which	could	be	one	potential	mechanism	by	which	the	
numbers	and	function	of	NK cells	decline	in	pancreatic	cancer	
patients	and	in	tumor-bearing	hu-BLT	mice	(51).	NK cell	func-
tion	is	significantly	downregulated	following	exposure	to	cancer	
cells	in	humans	(31,	51–53)	and	mice	(54,	55),	as	demonstrated	
by	 lower	 expression	 of	 activating	 surface	 receptors,	 decreased	
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cytotoxic	granule	release	and	cytotoxicity,	and	reduced	secretion	
of	TNF-α	and	IFN-γ	(56,	57).
In	this	paper,	we	demonstrate	the	association	of	both	KRAS	
mutation	in	the	pancreas	and	obesity	with	the	increased	loss	of	
NK cell	function	at	the	pre-malignant	stage	of	pancreatic	tumo-
rigenesis,	likely	paving	the	road	for	the	establishment,	invasion,	
and	metastasis	 of	 pancreatic	 tumors.	 Potential	 contribution	 of	
IL-6	 induced	by	peri-pancreatic	adipose	 tissue	 in	NK cell	 sup-
pression	is	also	shown	and	discussed.
MaTerials anD MeThODs
conditional Kras(g12D) Mouse Model 
and experimental Diet
To	study	the	effect	of	obesity	and	high-fat	calorie	diet	(HFCD)	
on	 NK	 function	 during	 pancreatic	 cancer	 development,	 the	
conditional	KRAS(G12D)	model	was	used	(58).	After	weaning,	
offspring	 of	 LSL-KRAS(G12D)	 and	 p48-Cre	 (or PDX-1-Cre)	
mice	were	 fed	either	a	HFCD	or	a	 lean	control	diet	 (CD)	 for	
3–4 months.	The	exact	composition	of	the	diets	was	previously	
described	 (59).	 The	 diets	 were	 obtained	 from	 Dyets,	 Inc.,	
Pennsylvania.	 After	 3–4  months,	 mice	 were	 euthanized,	 and	
the	entire	pancreas,	peri-pancreatic	adipose	tissues,	and	other	
organs	 were	 harvested.	 Formalin-fixed,	 paraffin-embedded	
tissues	were	sectioned	(4 µm)	and	stained	with	H&E.	Sections	
of	 pancreatic	 tissues	 were	 histologically	 evaluated	 by	 a	 gas-
trointestinal	pathologist	 for	 the	presence	and	stage	of	murine	
PanIN	lesions	as	described	previously	(55,	60).	Animal	studies	
were	approved	by	the	Chancellor’s	Animal	Research	Committee	
(ARC)	of	the	University	of	California,	Los	Angeles	in	accord-
ance	with	the	NIH	Guide	for	the	Care	and	Use	of	Laboratory	
Animals.	 Genotyping	 analysis	 was	 performed	 as	 described	
previously	(61).
Preparation of single cell suspension
To	prepare	a	single	cell	suspension	of	mice	tissues	for	subsequent	
analyses,	animals	were	sacrificed	and	spleen,	pancreas,	bone	mar-
row	from	femur,	peri-pancreatic	fat	and	peripheral	blood	were	
harvested.	Bone	marrow	cells	and	splenocytes	were	isolated,	as	
described	previously	(62).	The	pancreas	and	adipose	tissues	were	
immediately	cut	into	1 mm3	pieces	and	placed	into	a	digestion	
buffer	containing	1 mg/ml	collagenase	IV,	10 U/ml	DNAse,	and	
1%	bovine	serum	albumin	(BSA)	in	DMEM	media	and	incubated	
for	20 min	at	37°C	oven	on	a	150-rpm	shaker.	After	digestion,	the	
sample	was	filtered	through	a	40 µm	cell	strainer	and	centrifuged	
at	1,500 rpm	for	10 min	at	4°C.	The	pellet	was	re-suspended	in	
DMEM	media	 and	 cells	were	 counted.	 PBMCs	were	 obtained	
using	Ficoll-Hypaque	 centrifugation	of	 heparinized	peripheral	
blood	 specimens.	The	buffy	coat	 containing	PBMCs	were	har-
vested,	washed,	and	re-suspended	in	RPMI	1640	medium.
cell lines, reagents, and antibodies
RPMI	1640	supplemented	with	10%	fetal	bovine	serum	(FBS)	was	
used	for	culturing	mouse	NK cells,	T cells,	monocytes,	BM cells,	
splenocytes,	PBMCs,	pancreas,	and	adipose	cells.	ST63,	PanIN,	
and	KC	tumor	cells	were	cultured	in	RPMI	1640	supplemented	
with	 10%	 FBS.	 Lipopolysaccharides	 were	 purchased	 from	
Sigma-Aldrich	 (St.	 Louis,	 MO,	 USA).	 Recombinant	 IL-2	 was	
obtained	from	NIH-BRB.	Flow	antibodies	used	in	this	study	were	
purchased	 from	Biolegend	 (San	Diego,	 CA,	USA).	The	mouse	
NK cells	and	monocyte	purification	kits	were	obtained	from	Stem	
Cell	Technologies	(Vancouver,	BC,	Canada).
cell isolations and cultures
Natural	killer	cells	were	isolated	from	splenocytes	using	mouse	
NK  cells	 isolation	 kit	 (Stem-cells	 Technologies,	 Canada).	
Monocytes	were	isolated	from	BM cells	using	monocyte	isolation	
kit	 (Stem-cells	 Technologies,	 Canada).	The	 purity	 of	 NK  cells	
and	monocytes	was	greater	than	90%	based	on	flow	cytometric	
analysis	of	DX5	and	F4/80	antibodies,	respectively.
Bacteria sonication
sAJ2	 is	 a	 combination	 of	 eight	 different	 strains	 of	 sonicated	
Gram-positive	 probiotic	 bacteria	 (Streptococcus thermophiles, 
Bifidobacterium longum, Bifidobacterium breve, Bifidobacterium 
infantis, Lactobacillus acidophilus, Lactobacillus plantarum, 
Lactobacillus casei, and Lactobacillus bulgaricus)	as	demonstrated	
previously	(63).	For	sonication,	AJ2	was	weighed	and	re-suspended	
in	RPMI	1640	medium	containing	10%	FBS	at	a	concentration	of	
10 mg/ml.	The	bacteria	were	thoroughly	vortexed,	then	sonicated	
on	ice	for	15 s,	at	6–8	amplitudes.	Sonicated	samples	were	then	
incubated	for	30 s	on	ice.	After	every	five	pulses,	a	sample	was	
taken	to	observe	under	the	microscope	until	at	least	80%	of	cell	
walls	were	lysed.	It	was	determined	that	approximately	20	rounds	
of	 sonication/incubation	 on	 ice	 were	 conducted	 to	 achieve	
complete	sonication.	Finally,	the	sonicated	samples	(sAJ2)	were	
aliquoted	and	stored	in	a	−80°C	freezer	until	use.
generation of Osteoclasts  
and expansion of nK cells
Purified	 mouse	 monocytes	 from	 BM  cells	 were	 cultured	 in	
alpha-MEM	 medium	 supplemented	 with	 Macrophage	 Colony	
Stimulating	Factor	(M-CSF)	(25 ng/ml)	and	Receptor	Activator	
of	Nuclear	Factor	Kappa-Β	ligand	(RANKL)	(25 ng/ml).	Medium	
was	refreshed	every	3 days	with	fresh	alpha-MEM	supplemented	
with	 M-CSF	 and	 RANKL.	 Purified	 NK  cells	 from	 mice	 sple-
nocytes	 were	 activated	 with	 IL-2	 (10,000  U/ml)	 for	 18–20  h	
before	they	were	co-cultured	with	osteoclasts	and	sonicated	AJ2	
(NK:OCs:sAJ2	was	1:0.5:2)	or	LPS	(100 ng/ml).	The	culture	media	
was	refreshed	with	RPMI	1640	medium	supplemented	with	IL-2	
every	3 days	as	described	previously	(51).
surface staining
The	cells	were	washed	 twice	using	 ice-cold	PBS	with	 1%	BSA.	
Predetermined	optimal	concentrations	of	specific	mouse	mono-
clonal	 antibodies	were	added	 to	1 ×  105	 cells/50 μl	of	 cold	1%	
BSA + PBS	and	cells	were	incubated	on	ice	for	30 min.	Thereafter,	
cells	were	washed	in	cold	1%	BSA + PBS	and	brought	to	500 µl	
with	1%BSA + PBS.	Staining	was	performed	as	described	previ-
ously	 (64)	 and	 flow	 cytometric	 analysis	 was	 performed	 using	
Beckman	Coulter	Epics	XL	cytometer	(Brea,	CA)	and	results	were	
analyzed	in	FlowJo	vX	software	(Ashland,	OR,	USA).
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elisa
Single	ELISAs	were	performed	and	standard	curve	was	generated	
as	 described	 previously	 (65).	 A	 standard	 curve	 was	 generated	
by	 either	 two-	 or	 threefold	 dilution	 of	 recombinant	 cytokines	
provided	by	the	manufacturer	to	analyze	and	obtain	the	cytokine	
and	chemokine	concentration.
Multiplex cytokine/chemokine assay
The	levels	of	cytokines	and	chemokines	were	examined	by	a	com-
mercially	 available	multiplex	 assay	 (MILLIPLEX®	MAP	Mouse	
Cytokine/Chemokine	 Magnetic	 Bead	 Panel,	 EMD	 Millipore,	
Billerica,	MA,	USA).	A	standard	curve	was	generated	by	threefold	
dilution	of	recombinant	cytokines	provided	by	the	manufacturer	
to	determine	the	cytokine	concentrations.	The	data	were	analyzed	
by	the	proprietary	software	(xPONENT	4.2,	Millipore,	Billerica,	
MA,	USA).
51cr release cytotoxicity assay
The	 4-h	 51Cr	 release	 assay	 was	 performed,	 as	 demonstrated	
previously	(66).	Briefly,	different	numbers	of	effector	cells	were	
incubated	with	51Cr-labeled	ST63	target	cells	 for	4 h.	ST63	was	
previously	used	as	specific	targets	of	NK cells	(55,	67).	After	that,	
the	supernatants	were	harvested	from	each	sample	and	released	
radioactivity	was	counted	using	the	gamma	counter.	The	percent-
age	(%)	specific	cytotoxicity	was	calculated	as	follows:
	
% Cytotoxicity Experimental cpm spontaneous cpm
Total cpm sp
=
−
− ontaneous cpm
	
Lytic	units	(LU)	30/106	was	calculated	by	using	the	inverse	of	
the	number	of	effector	cells	needed	to	lyse	30%	of	tumor	target	
ST63	cells	× 100.
statistical analysis
Prism	7	software	was	used	for	the	statistical	analysis.	One-way	
ANOVA	 using	 Turkey’s	 multiple	 comparison	 tests	 was	 used	
to	 compare	 different	 groups.	 For	 cytotoxicity	 and	 cytokine	
analysis	either	duplicate	or	triplicate	samples	were	used	for	each	
experiment.	n	denotes	the	number	of	mice	used	for	the	experi-
ments.	The	following	symbols	represent	the	 levels	of	statistical	
significance	within	each	analysis,	***p-value	<0.001,	**p-value	
0.001–0.01,	*p-value	0.01–0.05.
resUlTs
Decreased Percentages of DX5+ nK cells 
and nK cell cytotoxic Function in Kc 
Mice Fed With hFcD
We	have	 recently	 demonstrated	 that	KC	mice	 fed	with	HFCD	
exhibited	 increased	body	weight	 as	well	 as	 augmented	 visceral	
adipose	 tissue	 (68)	 and	 generated	 significantly	more	 advanced	
pre-cancerous	PanIN-2	and	-3	lesions	when	compared	to	KC	mice	
on	CD	(55).	No	invasive	PDAC	could	be	found	in	KC	mice	fed	
with	either	CD	or	HFCD	at	3–4 months.	No	pancreatic	neoplastic	
lesions	were	 found	 in	WT	mice	 fed	with	 either	CD	or	HFCD.	
In	 addition,	 KC	 mice	 fed	 with	 HFCD	 had	 significantly	 more	
inflammation,	acinar	cell	loss,	and	increased	pancreatitis	score	as	
compared	to	KC	mice	fed	with	CD.	The	numbers	of	normal	ducts	
within	pancreas	was	much	less	in	KC	mice	fed	with	HFCD	when	
compared	to	those	fed	with	CD,	and	pancreatic	fibrosis	was	only	
observed	in	KC	mice	and	not	in	WT	mice	(55).
To	 evaluate	 the	 effect	 of	 KRAS	 mutation	 and	 HFCD,	 we	
determined	 the	 total	 numbers	 of	 CD45+	 immune	 cells,	 per-
centage	of	DX5+	NK cells,	and	total	numbers	of	NK cells	from	
different	tissue	compartments	of	WT	and	KC	mice	(Figure	S1	in	
Supplementary	Material).	On	average,	no	statistically	significant	
differences	could	be	observed	in	the	number	of	cultured	CD45+	
immune	 cells	 from	 different	 tissues	 between	 the	 four	 groups	
of	mice	(Figures	S1A,B	in	Supplementary	Material).	When	the	
percentages	of	DX5+	NK cells	were	determined	in	the	spleen,	
PBMCs,	 pancreas,	 and	 adipose	 tissues	 after	 culture,	 there	
was	 a	 consistent	 and	 significant	 decline	 in	 the	 percentages	 of	
DX5+	NK cells	within	WT	mice	 fed	with	HFCD	or	KC	mice	
fed	with	CD	as	well	as	HFCD,	exhibiting	the	following	profiles	
(WT/CD > WT/HFCD > KC/CD > KC/HFCD)	 (Figure	 S1A	
in	Supplementary	Material).	The	most	severe	decline	was	seen	
in	 KC	 mice	 fed	 with	 HFCD	 (Figure	 S1A	 in	 Supplementary	
Material).	Statistically	significant	differences	in	the	percentages	
of	DX5+	immune	subsets	in	bone	marrow	of	WT	and	KC	mice	
on	HFCD	and	those	of	WT	mice	on	CD	could	be	seen	(Figure	
S1B	in	Supplementary	Material).	The	decrease	in	the	percentages	
of	NK cells	was	not	due	 to	 the	decline	of	 total	populations	of	
CD45+	 immune	cells	 (Figure	S1A	and	S1B	 in	Supplementary	
Material)	 or	 total	 numbers	 of	 cells	 dissociated	 from	 different	
tissue	 compartments	 (Figure	 S2	 in	 Supplementary	 Material).	
In	 assessments	 of	 spleen,	 pancreas,	 adipose,	 and	 peripheral	
blood,	the	following	pattern	of	cytotoxicity	against	cancer	stem	
cells	 was	 observed	 (WT/CD > WT/HFCD >  KC/CD >  KC/
HFCD)	 (Figure	 S3A	 in	 Supplementary	Material).	The	 reverse	
profile	was	seen	for	the	secretion	of	cytokines,	IFN-γ,	and	IL-6,	
which	were	as	follows	(WT/CD < WT/HFCD < KC/CD < KC/
HFCD)	(Figures	S3B,C	in	Supplementary	Material).	In	contrast,	
bone	marrow	exhibited	the	opposite	profiles	of	cytotoxicity	and	
cytokine	 secretion,	 when	 compared	 to	 the	 spleen,	 pancreas,	
adipose,	 and	 peripheral	 blood	 (Figure	 S3D	 in	 Supplementary	
Material).	Since	IFN-γ	and	IL-6	secretions	were	increased	in	the	
cells	obtained	 from	 the	various	 tissues	of	KC	mice	on	HFCD,	
with	 the	 exception	 of	 BM	 (Figures	 S3B–D	 in	 Supplementary	
Material),	 we	 aimed	 to	 determine	 whether	 other	 cytokines	
were	modulated	similarly	or	differently,	using	Luminex	multi-
plex	cytokine	and	chemokine	assays.	As	 shown	 in	Table	S1	 in	
Supplementary	Material,	pancreatic	cells	from	KC	mice	fed	with	
HFCD	had	the	highest	levels	of	cytokine	secretion.	Interestingly,	
the	secretion	of	cytokines	was	similar	in	WT	mice	on	HFCD	and	
KC	on	CD,	and	both	were	higher	than	WT	on	CD	(Figures	S3B,C	
and	Table	S1	in	Supplementary	Material).	BM cells	exhibited	the	
inverse	profiles	of	spleen,	pancreas,	adipose	tissue,	and	peripheral	
blood,	demonstrating	less	cytokine	release	from	mice	on	HFCD	
(Figure	S3D	and	Table	S2	in	Supplementary	Material).	PBMCs	
isolated	from	peripheral	blood	of	mice	exhibited	similar	results	
to	those	isolated	from	the	pancreatic	cells	of	four	groups	of	mice,	
and	KC	mice	 fed	with	HFCD	had	 the	highest	 secretion	when	
compared	to	other	groups	of	mice	(Figures	S3B,C	and	Tables	S1	
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and	S3	in	Supplementary	Material).	Overall,	KC	mice	on	HFCD	
showed	the	highest	levels,	followed	by	KC	mice	fed	with	CD.	WT	
mice	on	HFCD	had	higher	secretion	of	inflammatory	cytokines	
when	compared	to	WT	on	CD	(Figures	S3B,C	and	Table	S3	in	
Supplementary	Material).	As	indicated	in	Section	“Materials	and	
Methods”	NK cell	cytotoxicity	was	determined	using	LU	30/106	
cells,	 since	 this	 allowed	us	 to	 summarize	 a	 large	body	of	data	
within	 the	 scatter	plots.	The	great	 agreement	 and	 relationship	
between	cytotoxicity	for	different	effector:target	(E:T)	ratios	and	
LU	30/106	is	shown	in	Figures	S4A,B	in	Supplementary	Material.
Decreased Tumor Killing and iFn-γ 
secretion by Purified nK cells From 
spleen of Kc Mice on hFcD
The	levels	of	NK cell	cytotoxicity	obtained	from	all	the	tissues	
examined	were	specific	to	NK cells	due	to	the	use	of	NK-specific	
target	cells	 to	determine	NK cell-mediated	cytotoxicity,	how-
ever,	the	same	cannot	be	said	for	IFN-γ	secretion,	since	other	
immune	effectors	within	the	tissues	might	have	contributed	to	
IFN-γ	 secretion.	Therefore,	 to	 establish	 the	 specific	 effect	 on	
the	NK cells,	we	purified	NK cells	from	the	spleens	of	WT	and	
KC	mice	on	CD	or	HFCD	and	NK cell-mediated	cytotoxicity	
as	well	as	IFN-γ	and	IL-6	secretion	were	determined.	Surface	
expression	of	DX5	was	determined	on	freshly	isolated	NK cells	
(Figure	S5A	 in	Supplementary	Material)	 and	on	 those	which	
were	 cultured	 (Figure	 S5B	 in	 Supplementary	 Material).	 No	
significant	changes	on	the	surface	expression	of	DX5	could	be	
observed	 in	 purified	NK  cells	 from	 four	 groups	 after	 culture	
(Figure	 S5B	 in	 Supplementary	 Material).	 The	 TLR4	 surface	
expression	was	also	analyzed	on	freshly	isolated	NK cells.	KC	
mice	 expressed	 higher	TLR4	 expression	 as	 compared	 to	WT	
mice,	 and	 KC	mice	 on	HFCD	 expressed	 higher	 TLR4	 when	
compared	 to	KC	mice	on	CD	(Figure 1A).	Similar	 to	spleen,	
pancreas,	and	adipose	cells,	purified	NK cells	from	spleen	acti-
vated	with	 IL-2	 (Figure 1B)	or	with	 IL-2 + LPS	 (Figure 1C)	
demonstrated	 the	 following	 patterns	 of	 cytotoxicity	 (WT/
CD > WT/HFCD > KC/CD > KC/HFCD).
In	contrast	to	secretion	of	IFN-γ	by	splenocytes,	PBMCs,	pan-
creas	and	adipose	tissues,	in	which	an	upregulation	of	cytokine	
secretion	could	be	seen	in	mice	on	HFCD,	NK cells	treated	with	
IL-2	 (Figure  1D;	 Tables	 S1,	 S3,	 S4	 and	 S5	 in	 Supplementary	
Material)	or	with	IL-2 + LPS	(Figure 1E)	from	KC	mice	fed	with	
HFCD	had	the	least	secretion	of	IFN-γ,	followed	by	KC	mice	fed	
with	CD	 (Figures  1D,E;	 Table	 S5	 in	 Supplementary	Material).	
Activated	NK cells	 from	WT	mice	on	HFCD	had	higher	 levels	
of	secretion	than	WT	mice	on	CD	(Figures 1D,E).	Cytotoxicity	
of	 IL-2-treated	NK cells	 cultured	with	 and	without	 autologous	
monocytes	also	followed	a	similar	trend	to	those	shown	above,	
except	the	levels	of	cytotoxicity	by	NK cells	isolated	from	WT	mice	
on	HFCD	and	KC	on	CD	were	comparable;	and	both	were	more	
than	NK cells	from	KC	mice	on	HFCD	(Figure 1F).	Treatment	
of	NK cells	with	 combination	of	 IL-2 + LPS	 in	 the	absence	of	
monocytes	lowered	cytotoxicity	substantially	when	compared	to	
NK  cells	 treated	with	 IL-2	 alone,	 exhibiting	 the	 same	 trend	 in	
cytotoxicity	as	seen	with	IL-2-activated	NK cells	within	the	four	
animal	groups.	In	the	presence	of	monocytes	an	increased	levels	
of	cytotoxicity	could	be	seen	in	all	four	groups	of	mice	exhibit-
ing	 the	same	trend,	when	compared	to	IL-2-activated	NK cells	
in	 the	 absence	 of	monocytes	 (Figure  1F).	 IL-2 +  LPS-treated	
NK cell-mediated	cytotoxicity	in	the	presence	of	monocytes	was	
substantially	lower	in	all	animal	groups	(Figure 1F).
When	synergistic	induction	of	IFN-γ	by	the	purified	NK cells	
was	assessed	between	the	four	groups	of	mice	activated	with	IL-2	
(Figures 1G,H)	or	IL-2 + LPS	(Figures 1G,I)	with	monocytes	
(Figure  1G),	 similar	 profiles	 of	 IFN-γ	 secretion,	 as	 seen	with	
IL-2-activated	NK cells	in	the	absence	of	monocytes	could	also	
be	observed	 (Figures 1G,I).	Similar	 to	PBMCs,	 IL-6	 secretion	
by	the	NK cells	was	higher	in	mice	on	HFCD	(please	see	below).	
T cells	isolated	and	cultured	in	the	same	manner	as	NK cells,	with	
and	without	monocytes,	were	 not	 able	 to	 kill	NK  cell-specific	
targets	(Figure	S6A	in	Supplementary	Material).	In	contrast	to	
NK  cells,	 no	 decrease	 in	 the	 induction	 of	 IFN-γ	 secretion	 by	
T cells	activated	with	IL-2 + LPS	and	cultured	with	monocytes	
could	 be	 observed	 in	 KC	mice	 on	HFCD	when	 compared	 to	
either	WT	 or	KC	mice	 on	CD	 (Figure	 S6B	 in	 Supplementary	
Material).	Similar	to	NK cells,	purified	T cells	from	WT	mice	on	
HFCD	demonstrated	increased	IFN-γ	secretion	when	compared	
to	WT	mice	on	CD	(Figure	S6B	in	Supplementary	Material).
Osteoclasts (Ocs) From Kc Mice  
on hFcD are Defective in increasing 
numbers and Killing of allogeneic  
nK cells From WT Mice
Osteoclasts	were	differentiated	from	the	BM-derived	monocytes	
for	each	mouse	group	and	used	for	 the	expansion	and	activa-
tion	of	allogeneic	NK cells	purified	from	the	spleen	of	WT	mice	
on	CD.	The	expression	of	RAE1-delta,	an	NKG2D	ligand,	and	
MHC-class	I	was	much	less	on	OCs	generated	from	KC	mice	as	
compared	to	WT	mice	(Figure 2A).	KC	mice	fed	with	HFCD	
had	the	least	expression	of	both	RAE1-delta	and	MHC-class	I	
when	 compared	 to	 either	WT	mice	 or	KC	mice	 fed	with	CD	
(Figure 2A).	As	 shown	 in	Figure 2B,	OCs	 from	KC	mice	 fed	
with	HFCD	when	cultured	with	allogeneic	NK cells	from	WT	
mice	 on	 CD	 in	 the	 presence	 of	 LPS	 had	 the	 least	 ability	 to	
expand	NK cells	when	compared	to	OCs	from	WT	mice	on	CD	
or	HFCD	or	KC	mice	fed	with	CD	(Figure 2B).	Similar	results	
were	 seen	 when	OCs	 were	 cultured	 with	 allogeneic	 NK  cells	
from	WT	mice	on	CD	in	the	presence	of	sAJ2	(data	not	shown).	
NK  cells	 from	WT	 mice	 when	 cultured	 with	 the	 OCs	 from	
WT	 or	 KC	mice	 on	HFCD	 in	 the	 presence	 of	 LPS	mediated	
much	 less	 cytotoxicity	when	 compared	 to	 those	 fed	with	CD	
(Figure 2C).	Similar	results	were	seen	in	the	presence	of	sAJ2	
(data	not	shown).	In	contrast,	NK cells	expanded	with	OCs	from	
KC	mice	fed	with	HFCD	treated	with	LPS	(Figures 2D,E)	and	
sAJ2	(Figures 2F,G)	secreted	the	highest	levels	of	IFN-γ	when	
compared	to	those	from	WT	mice	on	CD	or	HFCD,	or	KC	mice	
on	CD	(Figures 2D–G).	NK cells	expanded	by	osteoclasts	from	
both	WT	mice	on	HFCD	and	KC	mice	on	CD	secreted	higher	
levels	 of	 IFN-γ	 when	 compared	 to	 those	 obtained	 from	WT	
mice	 on	 the	 CD	 (Figures  2D–G).	 Accordingly,	 much	 higher	
levels	of	inflammatory	cytokines	and	chemokines	were	secreted	
from	 NK  cells	 expanded	 by	 OCs	 from	 KC	 mice	 on	 HFCD,	
FigUre 1 | Natural killer (NK) cells from KC mice fed with control diet (CD) or high-fat calorie diet when cultured with autologous monocytes demonstrated less 
cytotoxicity and decreased IFN-γ secretion when compared to WT mice fed with CD. WT and KC mice were fed with a CD or high-fat calorie diet as described in 
Section “Materials and Methods.” Splenocytes were harvested after animals were sacrificed and single cell suspension was prepared as described in Section 
“Materials and Methods” and used to purify NK cells. TLR4 surface expression on the purified NK cells from four groups of mice was analyzed using antibody 
staining followed by flow cytometric analysis. One of three representative experiments is shown in the (a). Purified NK cells from splenocytes were activated with 
IL-2 (10,000 U/ml) (n = 4) (B,D) or with IL-2 (10,000 U/ml) in the presence of LPS (100 ng/ml) (n = 4) (c,e) before they were used as effector cells in a standard 4-h 
51Chromium release assay. The lytic units (LUs) 30/106 cells were determined using the inverse number of NK cells required to lyse 30% of the ST63 cells ×100 
(n = 4) (B,c), and the supernatants were harvested after culture to determine the levels of IFN-γ secretion (n = 4) (D,e). IL-2-treated and IL-2 and LPS-treated 
NK cells as described in (c,e) were cultured with or without autologous monocytes at NK:monocytes; 1:0.5 ratio before they were used as effector cells in a 
standard 4-h 51Chromium release assay. The lytic units (LUs) 30/106 cells were determined using the inverse number of NK cells required to lyse 30% of the ST63 
cells ×100. One of five representative experiments is shown in (F). The supernatants were harvested to determine the levels of IFN-γ secretion. One of five 
representative experiments is shown in the (g). IL-2-treated NK cells (h) and IL-2 and LPS-treated NK cells (i) were cultured with autologous monocytes at 
NK:monocytes; 1:0.5 ratio before the supernatants were harvested to determine the levels of IFN-γ secretion (n = 3).
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followed	 by	 those	 expanded	 by	 osteoclasts	 from	KC	mice	 on	
CD	and	WT	mice	on	HFCD	(Figures 2D–G;	Tables	S6	and	S7	
in	Supplementary	Material).
secretion of il-6 by the Peri-Pancreatic 
adipose Tissue From Obese Mice is 
synergistically increased in the Presence 
of Decreased iFn-γ From nK cells
Peri-pancreatic	adipose	tissue	was	dissociated,	and	the	cells	were	
cultured	in	the	presence	or	absence	of	IL-2-activated	autologous	
NK cells	 and	 the	 levels	of	 IL-6	 and	 IFN-γ	were	determined	 in	
WT	mice	fed	with	CD	and	KC	mice	fed	with	HFCD	(Figure 3).	
NK cells	secreted	IL-6	moderately,	whereas	significant	secretion	
of	 IL-6	 could	 be	 seen	 by	 adipose-derived	 cells	 (Figure  3A).	
NK cells	synergized	with	adipose-derived	cells	in	the	induction	of	
IL-6	secretion,	but	the	levels	were	substantially	increased	in	those	
derived	from	obese	mice	fed	with	HFCD	as	compared	to	the	WT	
mice	 fed	 with	 CD	 (Figure  3A).	The	 inverse	 was	 seen	 for	 the	
secretion	of	IFN-γ	in	the	cultures	of	NK cells	with	adipose	tissue,	
in	which	increased	amounts	of	IFN-γ	secretion	and	augmented	
NK  cell-mediated	 cytotoxicity,	 could	 be	 seen	 by	WT	mice	 fed	
with	CD	and	less	with	KC	mice	fed	with	HFCD	(Figures 3B,C).	
Thus,	 increased	IL-6	secretion	was	observed	 in	the	presence	of	
decreased	 NK  cell-mediated	 cytotoxicity	 as	 well	 as	 decreased	
secretion	of	IFN-γ	in	KC	mice	fed	with	HFCD.
FigUre 2 | Allogeneic natural killer (NK) cells from WT mice fed with control diet (CD) expanded less and mediated less cytotoxicity, but demonstrated augmented 
IFN-γ secretion when cultured with osteoclasts from KC mice fed with high-fat calorie diet. WT and KC mice were fed with a CD or high-fat calorie diet as described 
in Section “Materials and Methods.” Bone marrow was harvested after animals were sacrificed and single cell suspension was prepared as described in Section 
“Materials and Methods.” Monocytes were purified from the BM cells and were used to generate OCs as described in Section “Materials and Methods.” Flow 
cytometric analysis was used to determine expression of RAE1-delta and MHC-class I on day 21 mature OCs (a). NK cells purified from splenocytes of WT mice 
fed with CD were activated with IL-2 (10,000 U/ml) and LPS (100 ng/ml), and cultured in the presence/absence of OCs from different mouse groups at NK:OCs; 
1:0.5 ratio, and the number of expanded NK cells were determined on the days shown in the (B). NK cells expanded by the OCs as described in (B) were used as 
effector cells in a standard 4-h 51Chromium release assay. The LUs 30/106 cells were determined as described in Figure 1B (c). NK cells were purified from WT 
splenocytes and cultured with OCs as described in (B,D,e) or treated with IL-2 in the presence of sonicated AJ2 (sAJ2) and cultured with OCs at the ratio of 
(0.5:1:2; OCs:NK:sAJ2) (F,g) and the supernatants were harvested on the days shown in the figures and secretion of IFN-γ were determined. One of three 
representative experiments is shown in Figure 2.
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compared to Kc Tumors, Panins express 
lower cD44 and are not susceptible to 
nK cells Mediated cytotoxicity
Single	 cell	 suspensions	 of	 PanINs	 and	 KC	 pancreatic	 tumors	
were	 obtained	 from	 KC	 mice	 and	 used	 to	 determine	 CD44	
surface	 receptor	 expression	 and	 susceptibility	 to	 NK  cells	
mediated	cytotoxicity.	As	shown	in	Figure	S7	in	Supplementary	
Material,	 PanINs	 expressed	 relatively	 lower	 levels	 of	 CD44	
expression	 (Figure	 S7A	 in	 Supplementary	Material),	 and	 they	
were	significantly	more	resistant	to	NK cells	mediated	cytotoxic-
ity,	when	 compared	 to	 either	KC	or	 ST63	 tumors	 (Figure	 S7B	
in	Supplementary	Material).	PBMCs	were	less	able	to	lyse	either	
PanINs	or	KC	tumors	(Figure	S7B	in	Supplementary	Material).	
These	data	indicated	that	PanINs	are	at	a	more	differentiated	stage	
than	KC	tumors.
DiscUssiOn
The	expansion	and	function	of	NK cells	are	known	to	be	severely	
suppressed	 in	 many	 cancer	 patients	 (51),	 however,	 it	 is	 still	
unknown	whether	the	establishment	of	cancer	is	responsible	for	
the	 suppression	of	NK  cells	 or	 lack	 of	NK  cell	 function	 at	 the	
pre-malignant,	 dysplastic	 stage	 is	 one	 of	 the	 driving	 forces	 for	
the	establishment	and	growth	of	cancer	or	both.	Studies	reported	
in	 this	paper	are	novel,	 since	 for	 the	first	 time	we	demonstrate	
that	NK cell	loss	occurs	at	the	pre-malignant	stage	of	cancer,	and	
FigUre 3 | Secretion of IL-6 by the peri-pancreatic adipose tissue from obese mice is synergistically increased in the presence of natural killer (NK) cells. Purified 
NK cells from splenocytes and adipocytes from the peri-pancreatic fat were obtained from WT mice on CD or KC mice on HFCD as described in Section “Materials 
and Methods.” NK cells treated with IL-2 (10,000 U/ml) in the presence and absence of autologous adipose cells at (NK:adipose cells; 1:1) were cultured and 
supernatants were harvested after 7 days and the secretion of IL-6 (a) and IFN-γ (B) were determined. One of the three representative experiments is shown in  
the figures. Cytotoxicity of NK cells cultured as described in (a,B) were assessed against ST63 tumor cells using the standard 4-h 51Chromium release assay.  
The LUs 30/106 cells were determined as described in Figure 1B (c). One of three representative experiments is shown in the figure.
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is	 associated	with	KRAS	mutation	 in	 the	pancreas	 and	obesity	
which	are	likely	contributing	factors	in	the	progression	of	cancer	
from	dysplastic	 stage	 to	overt	cancer.	We	demonstrate	 that	 the	
loss	of	NK cell	expansion	and	function	at	the	pre-neoplastic	stage	
correlates	with	increased	levels	and	intensity	of	dysplastic	lesions,	
increased	 inflammation,	fibrosis,	pancreatitis	 score,	and	 loss	of	
normal	ductal	structures	(55).	In	addition,	we	also	show	that	the	
combined	effects	of	KRAS	mutation	in	the	pancreas	and	obesity	
are	associated	with	the	greater	loss	of	NK cell	cytotoxic	function.
We	have	recently	shown	that	NK cells	specifically	target	and	
kill	cancer	stem	cells/undifferentiated	tumors,	and	are	activated	
to	secrete	IFN-γ	and	TNF-α	in	order	to	drive	the	differentiation	
of	tumors	(63).	Lack	or	loss	of	NK cell	expansion	and	function	
as	seen	in	KC	mice	on	HFCD	could	likely	be	a	contributing	fac-
tor	for	the	survival	of	cancer	stem	cells/undifferentiated	tumors	
in	addition	to	the	failure	of	NK cells	to	promote	differentiation	
of	 these	 tumors.	 We	 have	 also	 shown	 that	 NK-differentiated	
tumors	proliferate	or	expand	less,	and	exhibit	higher	expression	
of	MHC-class	 I,	CD54,	PD-L1,	 and	 lower	 expression	of	CD44	
surface	receptors	(69).	PanINs	express	less	CD44	and	are	resistant	
to	NK cell-mediated	cytotoxicity	demonstrating	more	of	 a	dif-
ferentiated	phenotype,	whereas	KC	tumors	express	higher	levels	
of	 CD44	 and	 are	 susceptible	 to	NK  cell-mediated	 cytotoxicity	
exhibiting	more	 of	 poorly	 differentiated	 phenotype	 (Figure	 S7	
in	 Supplementary	Material).	Therefore,	 based	on	 these	profiles	
one	may	expect	 lower	NK cell	 inactivation	 in	mice	 at	 the	pre-
neoplastic	 stage	 than	when	overt	cancer	 is	 established.	 Indeed,	
severe	inhibition	of	NK	cell	functions	is	seen	in	pancreatic	cancer	
patients,	whereas	 at	 the	 pre-neoplastic	 stages	 of	 tumorigenesis	
the	severity	of	NK	cell	suppression	may	be	 lower,	with	gradual	
increases	in	severity	when	the	cells	accumulate	more	mutations	
and	 become	 overt	 cancer	 (51).	 In	 addition,	 loss	 of	 NK  cell-
mediated	 cytotoxicity	 and	 severe	 decreases	 in	 IFN-γ	 secretion	
are	found	to	be	the	reasons	for	pancreatic	and	oral	tumor	growth	
in	hu-BLT	mice	(51,	70)	and	“manuscript	submitted.”
When	the	same	numbers	of	cells	dissociated	from	each	tissue	
were	cultured	from	four	groups	of	mice,	a	very	consistent	profile,	
with	 regards	 to	 decreased	 percentages	 of	 NK  cells,	 could	 be	
observed	in	KC	mice	on	HFCD.	Even	when	gingival	cells	from	
these	mice	were	dissociated	and	cultured	the	same	profiles	could	
be	seen	as	the	other	tissues	examined	(55).	This	could	be	due	to	
several	factors.	Since	percentages	of	NK cells	are	elevated	in	WT	
mice	on	CD,	it	could	be	that	either	the	tissue	microenvironment	
is	permissive	for	NK cell	proliferation	and/or	that	NK cells	have	
higher	cytotoxicity,	and	therefore	 they	could	 limit	and	restrict	
survival	of	other	immune	cells	and	as	such	greater	percentages	
of	NK cells	could	be	detected	in	WT	mice	on	CD	after	culture.	
Decreased	NK	cytotoxicity	in	KC	mice	as	compared	to	WT	mice	
mirrored	decreased	percentages	of	NK cells	in	cells	dissociated	
from	the	 tissues	of	 these	mice.	However,	 there	was	an	 inverse	
correlation	 between	 secretion	 of	 IFN-γ	 and	 those	 of	NK  cell-
mediated	 cytotoxicity	 when	 total	 cells	 from	 the	 dissociated	
tissues	 were	 cultured	 (Figure	 S3	 in	 Supplementary	Material).	
Although	such	profiles	could	be	due	to	split-anergized	NK cells,	
in	 which	 cytotoxicity	 is	 decreased	 but	 cytokine	 secretion	 is	
augmented	(71),	it	is	also	possible	that	activated	NK cells	may	in	
turn	activate	T cells	within	the	mixture	of	the	cells	resulting	in	the	
combined	NK	and	T cell	mediated	increases	in	IFN-γ	secretion.	
Indeed,	 due	 to	 the	 inactivation	 of	NK  cell	 function	 in	 cancer	
patients,	we	observe	faster	expansion	of	T cells	which	results	in	
FigUre 4 | Schematic representation of hypothetical model of interaction between NK cells, adipose tissue, and pancreatic tumors. Adipose tissue within and 
around tumor microenvironment can contribute to the increased proliferation of pancreatic tumors through the increase in induction of IL-6 in the presence of 
decreased IFN-γ secretion by the NK cells. NK cells and monocytes are recruited to the peri-pancreatic and pancreatic adipose tissue from the circulation, where 
they are conditioned by the adipose tissue to lose secretion of IFN-γ, while increasing synergistically secretion of IL-6 by the peri-pancreatic and pancreatic 
adipose-derived cells. Since pancreatic tumors have a predilection to grow in the adipose tissue, these tissues are likely to convert tumor suppressive NK cells, to 
tumor-promoting cells, by decreasing NK-mediated cytotoxicity and IFN-γ secretion and allowing an increased secretion of IL-6 within the tumor microenvironment. 
Increased IL-6 secretion is instrumental in aiding in tumor growth and expansion.
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the	decreased	populations	of	NK cells,	whereas	in	healthy	indi-
viduals	NK cells	continue	expanding	for	30–60 days	before	T cell	
expansion	takes	over	(51).	However,	when	NK cells	are	sorted	
from	spleen	and	their	functions	were	assessed	in	the	four	groups	
of	mice,	a	decrease	in	cytotoxicity	as	well	as	secretion	of	IFN-γ	
could	be	seen	in	autologous	NK cells	from	KC	mice.	Decrease	
in	 secretion	of	 IFN-γ	 by	 autologous	NK cells	 could	be	due	 to	
the	extent	of	defect	in	NK cells,	since	osteoclasts	from	KC	mice	
on	HFCD	although	severely	restricted	expansion	of	allogeneic	
NK  cells,	 and	 NK  cells	 exhibited	 decreased	 cytotoxicity,	 they	
showed	 increased	 secretion	 of	 IFN-γ.	 In	 contrast,	 monocytes	
from	 KC	 mice	 on	 HFCD	 decreased	 expansion,	 cytotoxicity,	
as	 well	 as	 IFN-γ	 secretion	 by	 autologous	 NK  cells	 indicating	
perhaps	 more	 severe	 inactivation	 of	 autologous	 NK  cells.	
Thus,	 depending	on	 the	 inflammatory	microenvironment	 and	
the	extent	of	defect	 in	NK cells	 and	 in	 those	 supporting	 their	
activation,	different	degrees	of	functional	loss	of	NK cells	may	be	
seen.	Indeed,	we	have	previously	reported	four	stages	of	NK cell	
maturation	 and	 activation	 depending	 on	 the	 competency	 of	
NK cells	 (72).	At	 stage	2,	cytotoxicity	 is	 suppressed	but	 secre-
tion	of	cytokines	is	induced	which	we	have	previously	coined	as	
split	anergy	in	NK cells	(72).	At	stage	3,	both	cytotoxicity	and	
cytokine	secretion	are	suppressed	or	lost	(72).	Therefore,	based	
on	these	stages	when	NK cells	 from	WT	mice	on	CD	are	cul-
tured	with	osteoclasts	from	KC	mice	fed	with	HFCD,	NK cells	
are	 likely	 in	 stage	 2,	 since	 they	 have	 no/lower	 cytotoxicity	 in	
the	 presence	 of	 increased	 cytokine	 secretion.	 However,	 when	
monocytes	are	cultured	with	autologous	NK cells	from	KC	mice	
on	HFCD,	majority	of	NK cells	could	likely	be	in	stage	3,	since	
both	cytotoxicity	and	secretion	of	cytokines	are	suppressed.	The	
latter	profiles	are	also	seen	in	pancreatic	cancer	patients	in	whom	
both	NK cell-mediated	cytotoxicity	and	secretion	of	cytokines	
are	compromised.
Osteoclasts	from	KC	mice	on	HFCD	express	much	lower	lev-
els	of	MHC-class	I	inhibitory	ligands	and	RAE1-delta	activating	
ligands,	suggesting	that	both	inhibitory	and	activating	ligands	for	
signaling	of	NK	cells	are	decreased.	The	loss	of	expression	was	
much	more	 severe	 on	KC	mice	 on	HFCD	as	 compared	 to	KC	
mice	on	CD	and	the	highest	expressions	were	seen	on	the	surface	
of	WT	mice	on	HFCD	or	CD.	The	decreased	levels	of	MHC-class	
I	and	RAE1-delta	detected	on	OCs	correlated	with	the	generation	
of	PanINs	in	KC	mice,	indicating	that	the	loss	of	surface	receptors	
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on	OCs	in	combination	with	decreased	expansion	and	function	
of	NK cells	may	be	a	better	indicator	of	PanIN	induction.
In	 contrast	 to	 other	 tissues,	 bone	 marrow	 from	 KC	 mice	
demonstrated	higher	NK	cytotoxicity	 in	 the	presence	of	 lower	
IFN-γ	secretion	(Figure	S3	in	Supplementary	Material).	At	the	
moment,	it	is	unclear	why	NK cells	from	bone	marrow	behave	
differently	 when	 compared	 to	 the	 other	 tissues	 examined,	
however,	 since	 NK  cells	 develop	 and	mature	 within	 BM	 it	 is	
possible	 that	 the	 microenvironment	 provides	 the	 primary	
activating	signals	which	drive	their	initial	activation,	and	when	
such	activated	NK cells	exit	to	the	periphery,	additional	signals	
from	 the	microenvironment	 drive	 them	 to	 second,	 third,	 and	
fourth	stages	of	NK cell	maturation	depending	on	the	levels	and	
intensities	of	signals	they	receive.
Since	loss	of	both	cytotoxicity	and	cytokine	secretion	can	be	
seen	in	NK cells	in	KC	mice	on	HFCD,	with	the	highest	surface	
receptor	 expression	 for	TLR4	 (Figure  1A),	 it	may	 be	 that	 the	
defect	in	NK	function	is	not	at	the	level	of	availability	of	TLRs	on	
NK cells,	but	at	the	levels	of	ligand	and/or	post	receptor	signal-
ing.	Delineating	the	defects	at	the	level	of	post	receptor	signaling	
for	TLR4	on	NK cells	as	well	as	the	binding	and	function	of	other	
key	 receptors	on	NK cells	 from	these	mice	will	be	part	of	our	
future	studies.
Synergistic	 increase	 in	 the	 IL-6	 secretion	 in	 KC/HFCD	 as	
compared	 to	WT/CD	 by	 the	 peri-pancreatic	 adipose-derived	
cells	with	NK cells	in	the	presence	of	decreased	IFN-γ	secretion	
(54%	decrease	 in	KC/HFCD	 as	 compared	 to	WT/CD),	 could	
be	one	mechanism	by	which	the	adipose	tissue	can	contribute	
to	 the	 increased	 proliferation	 of	 pancreatic	 tumors.	 Indeed,	
IL-6	is	one	of	the	major	drivers	of	PDAC	proliferation	(73–77)	
and	 suppression	 of	 NK	 function	 (78).	 Moreover,	 addition	 of	
IL-6	 to	 tumor/NK	 cultures	 inhibited	 NK-mediated	 IFN-γ	
secretion	in	our	previous	studies	(42,	69,	71,	79,	80).	Therefore,	
since	tumors	have	a	predilection	to	grow	in	the	adipose	tissue,	
these	 tissues	are	 likely	 to	convert	 tumor	suppressive	NK cells,	
to	 tumor-promoting	cells.	Blocking	 IL-6	may	not	only	 inhibit	
tumor	growth	but	also	it	may	rescue	NK cells	from	suppression	
mediated	 by	 the	 adipose	 tissue	 or	 tumor	 tissues	 and	 offer	 an	
attractive	and	effective	therapeutic	strategy	to	target	pancreatic	
tumors	(Figures 3	and	4).
Our	 studies	 support	 the	 long-standing	 notion	 that	 both	
genetic	and	environmental	factors	are	important	in	tumorigen-
esis,	and	places	NK cells	within	the	list	of	potential	factors	for	
the	establishment	and	progression	of	pancreatic	cancers,	 since	
NK cells	are	the	main	effectors	capable	of	eliminating	and	dif-
ferentiating	cancer	stem	like/undifferentiated	tumor.
eThics sTaTeMenT
Animal	 studies	 were	 approved	 by	 the	 Chancellor’s	 Animal	
Research	Committee	of	the	University	of	California,	Los	Angeles	
in	 accordance	 with	 the	 NIH	 Guide	 for	 the	 Care	 and	 Use	 of	
Laboratory	Animals.
aUThOr cOnTriBUTiOns
KK	performed	 the	majority	 of	 experiments,	 data	 analysis,	 and	
preparation	 of	 the	manuscript.	 H-HC	 was	 responsible	 for	 the	
breeding	and	feeding	of	 the	KC	and	WT	mice	and	histological	
analysis	 of	 the	 tissues.	 PT	 and	 JC	 assisted	 KK	 in	 performing	
experiments	 and	 in	 the	 preparation	 of	 the	 manuscript.	 AB	
assisted	in	preparation	and	editing	of	the	manuscript.	GE	oversaw	
the	work	with	 breeding	 and	 feeding	 of	KC	 and	WT	mice	 and	
assisted	 in	 the	 preparation	 of	 the	manuscript.	 AJ	 oversaw	 the	
overall	design	of	the	experiments,	data	analysis,	and	preparation	
of	the	manuscript.
acKnOWleDgMenTs
Authors	acknowledge	the	help	of	Ms.	Aune	Moro	and	Dr.	Han-
Ching	Tseng	in	performing	some	of	the	experiments.	This	paper	
is	dedicated	to	the	Memory	of	Mr.	Jeffrey	Ying	who	spearheaded	
the	support	of	cancer	research	from	his	XO	Club	family.	Jeffrey	
was	 a	 benevolent,	 caring	 and	 simply	 a	 wonderful	 individual,	
and	for	those	of	us	who	were	lucky	enough	to	have	known	him	
and	call	him	“my	friend”	it	was	a	blessing	and	an	honor.	He	will	
never	be	forgotten.	He	lives	on	in	our	hearts.
FUnDing
The	 study	was	 funded	 by	NIH	P01CA163200,	 PAPD,	 and	XO	
club.
sUPPleMenTarY MaTerial
The	Supplementary	Material	for	this	article	can	be	found	online	at	
https://www.frontiersin.org/articles/10.3389/fimmu.2018.01229/
full#supplementary-material.
reFerences
1.	 Collisson	EA,	Sadanandam	A,	Olson	P,	Gibb	WJ,	Truitt	M,	Gu	S,	et al.	Subtypes	
of	pancreatic	ductal	adenocarcinoma	and	their	differing	responses	to	therapy.	
Nat Med	(2011)	17(4):500–3.	doi:10.1038/nm.2344	
2.	 Pelosi	 E,	 Castelli	 G,	 Testa	 U.	 Pancreatic	 cancer:	 molecular	 characteriza-
tion,	 clonal	 evolution	 and	 cancer	 stem	 cells.	 Biomedicines	 (2017)	 5(4):65.	
doi:10.3390/biomedicines5040065	
3.	 Vincent	A,	Herman	J,	Schulick	R,	Hruban	RH,	Goggins	M.	Pancreatic	cancer.	
Lancet	(2011)	378(9791):607–20.	doi:10.1016/S0140-6736(10)62307-0	
4.	 Adamska	A,	Domenichini	A,	Falasca	M.	Pancreatic	ductal	adenocarcinoma:	
current	and	evolving	therapies.	Int J Mol Sci	(2017)	18(7):1338.	doi:10.3390/
ijms18071338	
5.	 Feldmann	G,	Maitra	A.	Molecular	genetics	of	pancreatic	ductal	adenocarci-
nomas	and	recent	 implications	 for	 translational	 efforts.	 J Mol Diagn	 (2008)	
10(2):111–22.	doi:10.2353/jmoldx.2008.070115	
6.	 Maitra	A,	Hruban	RH.	Pancreatic	cancer.	Annu Rev Pathol	(2008)	3:157–88.	
doi:10.1146/annurev.pathmechdis.3.121806.154305	
7.	 Moore	PS,	Orlandini	S,	Zamboni	G,	Capelli	P,	Rigaud	G,	Falconi	M,	 et  al.	
Pancreatic	 tumours:	 molecular	 pathways	 implicated	 in	 ductal	 cancer	 are	
involved	 in	ampullary	but	not	 in	exocrine	nonductal	or	endocrine	 tumori-
genesis.	Br J Cancer	(2001)	84(2):253–62.	doi:10.1054/bjoc.2000.1567	
8.	 Eser	S,	Schnieke	A,	Schneider	G,	Saur	D.	Oncogenic	KRAS	signalling	in	pan-
creatic	cancer.	Br J Cancer	(2014)	111(5):817–22.	doi:10.1038/bjc.2014.215	
9.	 Rachakonda	 PS,	 Bauer	 AS,	 Xie	 H,	 Campa	D,	 Rizzato	 C,	 Canzian	 F,	 et  al.	
Somatic	 mutations	 in	 exocrine	 pancreatic	 tumors:	 association	 with	
11
Kaur et al. NK Defects at Pre-Neoplastic Stage
Frontiers in Immunology | www.frontiersin.org June 2018 | Volume 9 | Article 1229
patient	 survival.	 PLoS One	 (2013)	 8(4):e60870.	 doi:10.1371/journal.pone.	
0060870	
10.	 Bournet	B,	Buscail	C,	Muscari	F,	Cordelier	P,	Buscail	L.	Targeting	KRAS	for	
diagnosis,	prognosis,	and	treatment	of	pancreatic	cancer:	hopes	and	realities.	
Eur J Cancer	(2016)	54:75–83.	doi:10.1016/j.ejca.2015.11.012	
11.	 Wang	H,	Maitra	A,	Wang	H.	Obesity,	 intrapancreatic	 fatty	 infiltration,	and	
pancreatic	 cancer.	 Clin Cancer Res	 (2015)	 21(15):3369–71.	 doi:10.1158/	
1078-0432.CCR-15-0718	
12.	 Renehan	AG,	Tyson	M,	Egger	M,	Heller	RF,	Zwahlen	M.	Body-mass	 index	
and	incidence	of	cancer:	a	systematic	review	and	meta-analysis	of	prospec-
tive	 observational	 studies.	 Lancet	 (2008)	 371(9612):569–78.	 doi:10.1016/
S0140-6736(08)60269-X	
13.	 Michaud	DS.	Obesity	and	pancreatic	cancer.	Recent Results Cancer Res	(2016)	
208:95–105.	doi:10.1007/978-3-319-42542-9_6	
14.	 Gottschlich	MM,	Mayes	T,	Khoury	JC,	Warden	GD.	Significance	of	obesity	
on	 nutritional,	 immunologic,	 hormonal,	 and	 clinical	 outcome	 parameters	
in	burns.	J Am Diet Assoc	(1993)	93(11):1261–8.	doi:10.1016/0002-8223(93)	
91952-M	
15.	 Marti	A,	Marcos	A,	Martinez	JA.	Obesity	and	immune	function	relationships.	
Obes Rev	(2001)	2(2):131–40.	doi:10.1046/j.1467-789x.2001.00025.x	
16.	 Fuster	JJ,	Ouchi	N,	Gokce	N,	Walsh	K.	Obesity-induced	changes	in	adipose	
tissue	microenvironment	and	their	impact	on	cardiovascular	disease.	Circ Res	
(2016)	118(11):1786–807.	doi:10.1161/CIRCRESAHA.115.306885	
17.	 Guzik	TJ,	Skiba	DS,	Touyz	RM,	Harrison	DG.	The	role	of	infiltrating	immune	
cells	in	dysfunctional	adipose	tissue.	Cardiovasc Res	(2017)	113(9):1009–23.	
doi:10.1093/cvr/cvx108	
18.	 Roebuck	BD,	Yager	JD	Jr,	Longnecker	DS,	Wilpone	SA.	Promotion	by	unsat-
urated	fat	of	azaserine-induced	pancreatic	carcinogenesis	 in	the	rat.	Cancer 
Res	(1981)	41(10):3961–6.	
19.	 Kraft	PL.	The	effect	of	dietary	fat	on	tumor	growth.	Regul Toxicol Pharmacol	
(1983)	3(3):239–51.	doi:10.1016/0273-2300(83)90031-4	
20.	 Farag	SS,	Caligiuri	MA.	Human	natural	killer	cell	development	and	biology.	
Blood Rev	(2006)	20(3):123–37.	doi:10.1016/j.blre.2005.10.001	
21.	 Rautela	J,	Souza-Fonseca-Guimaraes	F,	Hediyeh-Zadeh	S,	Delconte	RB,	Davis	
MJ,	 Huntington	 ND.	Molecular	 insight	 into	 targeting	 the	 NK	 cell	 immune	
response	to	cancer.	Immunol Cell Biol	(2018)	96:477–84.	doi:10.1111/imcb.12045	
22.	 Palmer	JM,	Rajasekaran	K,	Thakar	MS,	Malarkannan	S.	Clinical	relevance	of	
natural	killer	cells	following	hematopoietic	stem	cell	transplantation.	J Cancer	
(2013)	4(1):25–35.	doi:10.7150/jca.5049	
23.	 Grégoire	C,	Chasson	L,	Luci	C,	Tomasello	E,	Geissmann	F,	Vivier	E,	 et  al.	
The	 trafficking	 of	 natural	 killer	 cells.	 Immunol Rev	 (2007)	 220:169–82.	
doi:10.1111/j.1600-065X.2007.00563.x	
24.	 Yokoyama	WM,	Kim	S,	French	AR.	The	dynamic	life	of	natural	killer	cells.	
Annu Rev Immunol	 (2004)	 22:405–29.	 doi:10.1146/annurev.immunol.22.	
012703.104711	
25.	 Kim	S,	Iizuka	K,	Kang	HS,	Dokun	A,	French	AR,	Greco	S,	et al.	In	vivo	devel-
opmental	stages	in	murine	natural	killer	cell	maturation.	Nat Immunol	(2002)	
3(6):523–8.	doi:10.1038/ni796	
26.	 Colucci	F,	Caligiuri	MA,	Di	Santo	 JP.	What	does	 it	 take	 to	make	a	natural	
killer?	Nat Rev Immunol	(2003)	3(5):413–25.	doi:10.1038/nri1088	
27.	 Martinet	L,	Smyth	MJ.	Balancing	natural	killer	cell	activation	through	paired	
receptors.	Nat Rev Immunol	(2015)	15(4):243–54.	doi:10.1038/nri3799	
28.	 Lam	RA,	Chwee	JY,	Le	Bert	N,	Sauer	M,	Pogge	von	Strandmann	E,	Gasser	S.	
Regulation	of	self-ligands	for	activating	natural	killer	cell	receptors.	Ann Med	
(2013)	45(4):384–94.	doi:10.3109/07853890.2013.792495	
29.	 Lanier	LL.	Up	on	the	tightrope:	natural	killer	cell	activation	and	inhibition.	
Nat Immunol	(2008)	9(5):495–502.	doi:10.1038/ni1581	
30.	 Kumar	 S.	 Natural	 killer	 cell	 cytotoxicity	 and	 its	 regulation	 by	 inhibitory	
receptors.	Immunology	(2018).	doi:10.1111/imm.12921
31.	 Konjevic	G,	Vuletić	A,	Mirjačić	Martinović	K,	Colović	N,	Čolović	M,	Jurišić	V.	
Decreased	 CD161	 activating	 and	 increased	 CD158a	 inhibitory	 receptor	
expression	on	NK cells	 underlies	 impaired	NK cell	 cytotoxicity	 in	patients	
with	 multiple	 myeloma.	 J Clin Pathol	 (2016).	 doi:10.1136/jclinpath-2016-	
203614	
32.	 Vuletic	 A,	 Jurišić	 V,	 Jovanić	 I,	 Milovanović	 Z,	 Nikolić	 S,	 Konjević	 G.	
Distribution	of	several	activating	and	inhibitory	receptors	on	CD3(-)CD56(+)	
NK cells	 in	 regional	 lymph	nodes	of	melanoma	patients.	 J Surg Res	 (2013)	
183(2):860–8.	doi:10.1016/j.jss.2013.02.025	
33.	 Vivier	E,	Tomasello	E,	Baratin	M,	Walzer	T,	Ugolini	S.	Functions	of	natural	
killer	cells.	Nat Immunol	(2008)	9(5):503–10.	doi:10.1038/ni1582	
34.	 Gasser	S,	Orsulic	S,	Brown	EJ,	Raulet	DH.	The	DNA	damage	pathway	regu-
lates	 innate	 immune	system	ligands	of	 the	NKG2D	receptor.	Nature	 (2005)	
436(7054):1186–90.	doi:10.1038/nature03884	
35.	 Bauer	S,	Groh	V,	Wu	J,	Steinle	A,	Phillips	JH,	Lanier	LL,	et al.	Activation	of	
NK cells	and	T cells	by	NKG2D,	a	receptor	for	stress-inducible	MICA.	Science	
(1999)	285(5428):727–9.	doi:10.1126/science.285.5428.727	
36.	 Moretta	A,	Marcenaro	E,	Parolini	S,	Ferlazzo	G,	Moretta	L.	NK cells	at	 the	
interface	 between	 innate	 and	 adaptive	 immunity.	Cell Death Differ	 (2008)	
15(2):226–33.	doi:10.1038/sj.cdd.4402170	
37.	 Nieswandt	 B,	Hafner	M,	 Echtenacher	 B,	Männel	DN.	 Lysis	 of	 tumor	 cells	
by	 natural	 killer	 cells	 in	 mice	 is	 impeded	 by	 platelets.	 Cancer Res	 (1999)	
59(6):1295–300.	
38.	 Nouroz	 F,	 Bibi	 F,	 Norean	 S,	Masoodd	N.	 Natural	 killer	 cells	 enhance	 the	
immune	surveillance	of	cancer.	Egypt J Med Hum Genet	(2016)	17(2):149–54.	
doi:10.1016/j.ejmhg.2015.08.006	
39.	 Kaur	K,	Nanut	MP,	Ko	MW,	Safaie	T,	Kos	J,	Jewett	A.	Natural	killer	cells	target	
and	differentiate	cancer	stem-like	cells/undifferentiated	tumors:	strategies	to	
optimize	 their	 growth	 and	 expansion	 for	 effective	 cancer	 immunotherapy.	
Curr Opin Immunol	(2018)	51:170–80.	doi:10.1016/j.coi.2018.03.022	
40.	 Trinchieri	G.	Biology	of	natural	killer	cells.	Adv Immunol	(1989)	47:187–376.	
doi:10.1016/S0065-2776(08)60664-1	
41.	 Lanier	 LL.	 NK  cell	 recognition.	 Annu Rev Immunol	 (2005)	 23:225–74.	
doi:10.1146/annurev.immunol.23.021704.115526	
42.	 Tseng	HC,	Arasteh	A,	Paranjpe	A,	Teruel	A,	Yang	W,	Behel	A,	et al.	Increased	
lysis	 of	 stem	 cells	 but	 not	 their	 differentiated	 cells	 by	 natural	 killer	 cells;	
de-differentiation	 or	 reprogramming	 activates	 NK  cells.	 PLoS One	 (2010)	
5(7):e11590.	doi:10.1371/journal.pone.0011590	
43.	 Brauner	 H,	 Elemans	 M,	 Lemos	 S,	 Broberger	 C,	 Holmberg	 D,	
Flodström-Tullberg	M,	et al.	Distinct	phenotype	and	function	of	NK cells	in	
the	pancreas	of	nonobese	diabetic	mice.	 J Immunol	 (2010)	184(5):2272–80.	
doi:10.4049/jimmunol.0804358	
44.	 Sideras	 K,	 Braat	 H,	 Kwekkeboom	 J,	 van	 Eijck	 CH,	 Peppelenbosch	 MP,	
Sleijfer	S,	et al.	Role	of	the	immune	system	in	pancreatic	cancer	progression	
and	 immune	 modulating	 treatment	 strategies.	 Cancer Treat Rev	 (2014)	
40(4):513–22.	doi:10.1016/j.ctrv.2013.11.005	
45.	 Hori	M,	Takahashi	M,	Hiraoka	N,	Yamaji	T,	Mutoh	M,	Ishigamori	R,	et al.	
Association	of	pancreatic	fatty	infiltration	with	pancreatic	ductal	adenocarci-
noma.	Clin Transl Gastroenterol	(2014)	5(3):e53.	doi:10.1038/ctg.2014.5	
46.	 Chang	HH,	Moro	A,	Takakura	K,	Su	HY,	Mo	A,	Nakanishi	M,	et al.	Incidence	
of	pancreatic	cancer	is	dramatically	increased	by	a	high	fat,	high	calorie	diet	
in	 KrasG12D	mice.	PLoS One	 (2017)	 12(9):e0184455.	 doi:10.1371/journal.
pone.0184455	
47.	 Catalán	V,	Gómez-Ambrosi	J,	Rodríguez	A,	Frühbeck	G.	Adipose	tissue	immu-
nity	and	cancer.	Front Physiol	(2013)	4:275.	doi:10.3389/fphys.2013.00275	
48.	 Divella	R,	De	Luca	R,	Abbate	I,	Naglieri	E,	Daniele	A.	Obesity	and	cancer:	
the	role	of	adipose	tissue	and	adipo-cytokines-induced	chronic	inflammation.	
J Cancer	(2016)	7(15):2346–59.	doi:10.7150/jca.16884	
49.	 Tan	C,	Yaffee	PM,	 Jamil	 LH,	Lo	 SK,	Nissen	N,	Pandol	 SJ,	 et  al.	 Pancreatic	
cancer	 cachexia:	 a	 review	 of	 mechanisms	 and	 therapeutics.	 Front Physiol	
(2014)	5:88.	doi:10.3389/fphys.2014.00088	
50.	 Degrate	 L,	 Nobili	 C,	 Franciosi	 C,	 Caprotti	 R,	 Brivio	 F,	 Romano	 F,	 et  al.	
Interleukin-2	immunotherapy	action	on	innate	immunity	cells	in	peripheral	
blood	and	tumoral	tissue	of	pancreatic	adenocarcinoma	patients.	Langenbecks 
Arch Surg	(2009)	394(1):115–21.	doi:10.1007/s00423-008-0393-4	
51.	 Kaur	 K,	 Cook	 J,	 Park	 SH,	 Topchyan	 P,	 Kozlowska	 A,	 Ohanian	 N,	 et  al.	
Novel	 strategy	 to	 expand	 super-charged	NK cells	with	 significant	potential	
to	lyse	and	differentiate	cancer	stem	cells:	differences	in	NK	expansion	and	
function	between	healthy	and	cancer	patients.	Front Immunol	(2017)	8:297.	
doi:10.3389/fimmu.2017.00297	
52.	 Accomando	WP,	Wiencke	JK,	Houseman	EA,	Butler	RA,	Zheng	S,	Nelson HH,	
et al.	Decreased	NK cells	in	patients	with	head	and	neck	cancer	determined	
in	 archival	 DNA.	 Clin Cancer Res	 (2012)	 18(22):6147–54.	 doi:10.1158/	
1078-0432.CCR-12-1008	
53.	 Mirjacic	Martinovic	 KM,	 Babović	 NLJ,	 Džodić	 RR,	 Jurišić	 VB,	 Tanić	 NT,	
Konjević	GM.	Decreased	expression	of	NKG2D,	NKp46,	DNAM-1	receptors,	
and	 intracellular	 perforin	 and	 STAT-1	 effector	molecules	 in	 NK  cells	 and	
12
Kaur et al. NK Defects at Pre-Neoplastic Stage
Frontiers in Immunology | www.frontiersin.org June 2018 | Volume 9 | Article 1229
their	dim	and	bright	subsets	in	metastatic	melanoma	patients.	Melanoma Res	
(2014)	24(4):295–304.	doi:10.1097/CMR.0000000000000072	
54.	 Andrade	Mena	CE,	Orbach-Arbouys	S,	Mathe	G.	Enhancement	of	NK-cell	
activity	in	normal	and	tumor-bearing	mice	after	administration	of	aclacino-
mycin.	Chemotherapy	(1986)	32(2):142–7.	doi:10.1159/000238406	
55.	 Kaur	 K,	 Chang	 HH,	 Cook	 J,	 Eibl	 G,	 Jewett	 A.	 Suppression	 of	 gingival	
NK cells	 in	precancerous	 and	 cancerous	 stages	 of	 pancreatic	 cancer	 in	KC	
and	 BLT-humanized	 mice.	 Front Immunol	 (2017)	 8:1606.	 doi:10.3389/
fimmu.2017.01606	
56.	 Halder	RC,	Almasi	A,	Sagong	B,	Leung	J,	Jewett	A,	Fiala	M.	Curcuminoids	and	
omega-3	fatty	acids	with	anti-oxidants	potentiate	cytotoxicity	of	natural	killer	
cells	 against	 pancreatic	 ductal	 adenocarcinoma	 cells	 and	 inhibit	 interferon	
gamma	 production.	 Front Physiol	 (2015)	 6:129.	 doi:10.3389/fphys.2015.	
00129	
57.	 Peng	 YP,	 Zhang	 JJ,	 Liang	 WB,	 Tu	 M,	 Lu	 ZP,	 Wei	 JS,	 et  al.	 Elevation	 of	
MMP-9	and	IDO	induced	by	pancreatic	cancer	cells	mediates	natural	killer	
cell	dysfunction.	BMC Cancer	(2014)	14:738.	doi:10.1186/1471-2407-14-738	
58.	 Hingorani	 SR,	 Petricoin	EF,	Maitra	A,	Rajapakse	V,	King	C,	 Jacobetz	MA,	
et al.	Preinvasive	and	invasive	ductal	pancreatic	cancer	and	its	early	detection	
in	 the	mouse.	Cancer Cell	 (2003)	 4(6):437–50.	 doi:10.1016/S1535-6108(03)	
00309-X	
59.	 Dawson	DW,	Hertzer	K,	Moro	A,	Donald	G,	Chang	HH,	Go	VL,	et al.	High-
fat,	high-calorie	diet	promotes	early	pancreatic	neoplasia	in	the	conditional	
KrasG12D	 mouse	 model.	 Cancer Prev Res (Phila)	 (2013)	 6(10):1064–73.	
doi:10.1158/1940-6207.CAPR-13-0065	
60.	 Hruban	 RH,	 Adsay	 NV,	 Albores-Saavedra	 J,	 Compton	 C,	 Garrett	 ES,	
Goodman	SN,	et al.	Pancreatic	intraepithelial	neoplasia:	a	new	nomenclature	
and	classification	system	for	pancreatic	duct	lesions.	Am J Surg Pathol	(2001)	
25(5):579–86.	doi:10.1097/00000478-200105000-00003	
61.	 Funahashi	H,	Satake	M,	Dawson	D,	Huynh	NA,	Reber	HA,	Hines	OJ,	et al.	
Delayed	progression	of	pancreatic	 intraepithelial	neoplasia	 in	a	conditional	
Kras(G12D)	mouse	model	by	a	selective	cyclooxygenase-2	inhibitor.	Cancer 
Res	(2007)	67(15):7068–71.	doi:10.1158/0008-5472.CAN-07-0970	
62.	 Tseng	 HC,	 Kanayama	 K,	 Kaur	 K,	 Park	 SH,	 Park	 S,	 Kozlowska	 A,	 et  al.	
Bisphosphonate-induced	 differential	 modulation	 of	 immune	 cell	 function	
in	 gingiva	 and	 bone	 marrow	 in  vivo:	 role	 in	 osteoclast-mediated	 NK  cell	
activation.	 Oncotarget	 (2015)	 6(24):20002–25.	 doi:10.18632/oncotarget.	
4755	
63.	 Bui	 VT,	 Tseng	 HC,	 Kozlowska	 A,	Maung	 PO,	 Kaur	 K,	 Topchyan	 P,	 et  al.	
Augmented	 IFN-gamma	 and	 TNF-alpha	 induced	 by	 probiotic	 bacteria	 in	
NK cells	mediate	differentiation	of	stem-like	tumors	leading	to	inhibition	of	
tumor	growth	and	reduction	in	inflammatory	cytokine	release;	regulation	by	
IL-10.	Front Immunol	(2015)	6:576.	doi:10.3389/fimmu.2015.00576	
64.	 Jewett	 A,	 Bonavida	 B.	 Interferon-alpha	 activates	 cytotoxic	 function	 but	
inhibits	interleukin-2-mediated	proliferation	and	tumor	necrosis	factor-alpha	
secretion	 by	 immature	 human	 natural	 killer	 cells.	 J Clin Immunol	 (1995)	
15(1):35–44.	doi:10.1007/BF01489488	
65.	 Jewett	A,	Bonavida	B.	Target-induced	inactivation	and	cell	death	by	apoptosis	
in	a	subset	of	human	NK cells.	J Immunol	(1996)	156(3):907–15.	
66.	 Jewett	A,	Wang	MY,	Teruel	A,	Poupak	Z,	Bostanian	Z,	Park	NH.	Cytokine	
dependent	 inverse	 regulation	 of	 CD54	 (ICAM1)	 and	 major	 histocompat-
ibility	 complex	 class	 I	 antigens	 by	 nuclear	 factor	 kappaB	 in	 HEp2	 tumor	
cell	 line:	effect	on	the	function	of	natural	killer	cells.	Hum Immunol	 (2003)	
64(5):505–20.	doi:10.1016/S0198-8859(03)00039-9	
67.	 Regunathan	J,	Chen	Y,	Wang	D,	Malarkannan	S.	NKG2D	receptor-mediated	
NK  cell	 function	 is	 regulated	 by	 inhibitory	 Ly49	 receptors.	 Blood	 (2005)	
105(1):233–40.	doi:10.1182/blood-2004-03-1075	
68.	 Hertzer	KM,	Xu	M,	Moro	A,	Dawson	DW,	Du	L,	Li	G,	 et  al.	Robust	 early	
inflammation	 of	 the	 peripancreatic	 visceral	 adipose	 tissue	 during	 diet-	
induced	obesity	in	the	KrasG12D	model	of	pancreatic	cancer.	Pancreas	(2016)	
45(3):458–65.	doi:10.1097/MPA.0000000000000497	
69.	 Kozlowska	AK,	 Tseng	HC,	 Kaur	 K,	 Topchyan	 P,	 Inagaki	 A,	 Bui	 VT,	 et  al.	
Resistance	 to	 cytotoxicity	 and	 sustained	 release	 of	 interleukin-6	 and	 inter-
leukin-8	in	the	presence	of	decreased	interferon-gamma	after	differentiation	
of	glioblastoma	by	human	natural	killer	cells.	Cancer Immunol Immunother	
(2016)	65(9):1085–97.	doi:10.1007/s00262-016-1866-x	
70.	 Kaur	K,	Topchyan	P,	Kozlowska	AK,	Ohanian	N,	Chiang	J,	Maung	PO,	et al.	
Super-charged	NK cells	 inhibit	growth	and	progression	of	stem-like/poorly	
differentiated	oral	 tumors	 in vivo	 in	humanized	BLT	mice;	effect	on	tumor	
differentiation	 and	 response	 to	 chemotherapeutic	 drugs.	Oncoimmunology	
(2018)	7(5):e1426518.	doi:10.1080/2162402X.2018.1426518	
71.	 Kozlowska	AK,	Topchyan	P,	Kaur	K,	 Tseng	HC,	Teruel	A,	Hiraga	T,	 et  al.	
Differentiation	by	NK cells	 is	a	prerequisite	for	effective	targeting	of	cancer	
stem	cells/poorly	differentiated	tumors	by	chemopreventive	and	chemothera-
peutic	drugs.	J Cancer	(2017)	8(4):537–54.	doi:10.7150/jca.15989	
72.	 Jewett	A,	Man	YG,	Tseng	HC.	Dual	functions	of	natural	killer	cells	in	selec-
tion	and	differentiation	of	stem	cells;	role	in	regulation	of	inflammation	and	
regene	ration	of	tissues.	J Cancer	(2013)	4(1):12–24.	doi:10.7150/jca.5519	
73.	 Kim	HW,	Lee	JC,	Paik	KH,	Kang	J,	Kim	J,	Hwang	JH.	Serum	interleukin-6	
is	 associated	 with	 pancreatic	 ductal	 adenocarcinoma	 progression	 pattern.	
Medicine (Baltimore)	(2017)	96(5):e5926.	doi:10.1097/MD.0000000000005926	
74.	 Long	 KB,	 Tooker	 G,	 Tooker	 E,	 Luque	 SL,	 Lee	 JW,	 Pan	 X,	 et  al.	 IL6	
receptor	 blockade	 enhances	 chemotherapy	 efficacy	 in	 pancreatic	 Ductal	
Adenocarcinoma.	 Mol Cancer Ther	 (2017)	 16(9):1898–908.	 doi:10.1158/	
1535-7163.MCT-16-0899	
75.	 Nagathihalli	NS,	Castellanos	JA,	VanSaun	MN,	Dai	X,	Ambrose	M,	Guo	Q,	
et al.	Pancreatic	stellate	cell	secreted	IL-6	stimulates	STAT3	dependent	inva-
siveness	of	pancreatic	 intraepithelial	neoplasia	 and	 cancer	 cells.	Oncotarget	
(2016)	7(40):65982–92.	doi:10.18632/oncotarget.11786	
76.	 Goumas	FA,	Holmer	R,	Egberts	JH,	Gontarewicz	A,	Heneweer	C,	Geisen	U,	
et al.	Inhibition	of	IL-6	signaling	significantly	reduces	primary	tumor	growth	
and	 recurrences	 in	 orthotopic	 xenograft	 models	 of	 pancreatic	 cancer.	 Int 
J Cancer	(2015)	137(5):1035–46.	doi:10.1002/ijc.29445	
77.	 Lesina	 M,	 Kurkowski	 MU,	 Ludes	 K,	 Rose-John	 S,	 Treiber	 M,	 Klöppel	 G,	
et al.	Stat3/Socs3	activation	by	IL-6	 transsignaling	promotes	progression	of	
pancreatic	 intraepithelial	 neoplasia	 and	 development	 of	 pancreatic	 cancer.	
Cancer Cell	(2011)	19(4):456–69.	doi:10.1016/j.ccr.2011.03.009	
78.	 Xu	 Y,	 Sun	 J,	 Sheard	MA,	 Tran	 HC,	Wan	 Z,	 Liu	WY,	 et  al.	 Lenalidomide	
overcomes	suppression	of	human	natural	killer	cell	anti-tumor	functions	by	
neuroblastoma	 microenvironment-associated	 IL-6	 and	 TGFbeta1.	 Cancer 
Immunol Immunother	 (2013)	 62(10):1637–48.	 doi:10.1007/s00262-013-	
1466-y	
79.	 Magister	 Š,	Tseng	HC,	Bui	VT,	Kos	 J,	 Jewett	A.	Regulation	 of	 split	 anergy	
in	 natural	 killer	 cells	 by	 inhibition	 of	 cathepsins	 C	 and	H	 and	 cystatin	 F.	
Oncotarget	(2015)	6(26):22310–27.	doi:10.18632/oncotarget.4208	
80.	 Jewett	A,	Cacalano	NA,	Teruel	A,	 Romero	M,	Rashedi	M,	Wang	M,	 et  al.	
Inhibition	of	nuclear	factor	kappa	B	(NFkappaB)	activity	in	oral	tumor	cells	
prevents	depletion	of	NK cells	and	increases	their	functional	activation.	Cancer 
Immunol Immunother	 (2006)	 55(9):1052–63.	 doi:10.1007/s00262-005-	
0093-7	
Conflict of Interest Statement:	The	authors	declare	 that	 the	 research	was	 con-
ducted	in	the	absence	of	any	commercial	or	financial	relationships	that	could	be	
construed	as	a	potential	conflict	of	interest.
Copyright © 2018 Kaur, Chang, Topchyan, Cook, Barkhordarian, Eibl and Jewett. 
This is an open-access article distributed under the terms of the Creative Commons 
Attribution License (CC BY). The use, distribution or reproduction in other forums 
is permitted, provided the original author(s) and the copyright owner are credited 
and that the original publication in this journal is cited, in accordance with accepted 
academic practice. No use, distribution or reproduction is permitted which does not 
comply with these terms.
